UHSF News
Cordys Analytics Awarded Prestigious Eurostars Grant for AI-Powered Cardiovascular Diagnostics Project
Cordys Analytics is proud to announce that it has been awarded a prestigious Eurostars grant.
Read More...CryoCloud secures a 500k pre-seed investment to accelerate structure- based drug design with their cloud-native cryo-EM data analysis platform
We are happy to welcome our new portfolio company Cryocloud! Together with Nina Capital and ROM Utrecht Region we have invested € 500K to help the company in their mission to accelerate protein structure determination.
Read More...Ascencia raises seed capital investment for further development of their lab digitization technology
Ascenscia is an emerging tech startup in laboratory automation. Their product comprises a highly specialized voice assistant for scientific laboratories. It understands scientific terminologies and workflows efficiently and enables scientists to communicate with other lab systems by voice.
Read More...Synerkine Pharma secures EUR 12.1 million to accelerate novel pain therapeutics towards clinical proof-of-concept
Synerkine Pharma, a Dutch biopharmaceutical company creating innovative pain solutions, today announced an extension of its Series A financing led by Flerie with support from new investors, InnovationQuarter Capital and Utrecht Health Seed Fund, and existing investor Thuja Capital.
Read More...Academic Startup Competition – 4th Edition – APPLICATIONS OPEN
The Academic Startup Competition (ASC) is a joint initiative of Techleap, UNL, NFU, NAE, UTwente, VU and EZK. The competition offers a curated batch of 20 selected academic startups the chance to showcase themselves to an audience of (international) investors and businesses.
Read More...UMC Utrecht spin-out Cordys Analytics secures investment for improved early detection of heart disease.
LUMO Labs, ROM Utrecht Region and Utrecht Health Seed Fund are investing 900,000 euros in Cordys Analytics. The startup is a Dutch healthtech spin-out from the University Medical Center Utrecht (UMCU) and incubated at UtrechtInc.
Read More...Phlox Therapeutics Raises Additional Seed Funding to Further Develop RNA Therapies for Genetic Laminopathies
A very warm welcome to new portfolio company Phlox Therapeutics, a private biotechnology company specializing in developing innovative RNA-therapeutics for rare genetic cardiomyopathies.
Read More...Valentina Vignali appointed as Investment Associate
Utrecht Holdings welcomes Valentina Vignali to the team. Valentina is about to obtain a PhD in Biomedical Engineering from the University of Groningen and brings experience from working in academia and venture capital.
Read More...